Resolution by the board of directors to issue new shares through the capitalization of retained earnings.
· Issued by Maxigen Biotech Inc.
Close
Today's Information
Provided by: MAXIGEN BIOTECH INC.
SEQ_NO
2
Date of announcement
2022/03/21
Time of announcement
20:55:17
Subject
Resolution by the board of directors to issue new
shares through the capitalization of retained earnings.
Date of events
2022/03/21
To which item it meets
paragraph 11
Statement
1.Date of the board of directors resolution:2022/03/21
2.Source of capital increase funds:retained earnings
3.Whether to adopt shelf registration (Yes, please state issuance period/No):
No
4.Total monetary value of the issuance and number of shares issued (shares
issued not including those distributed to employees if consisting in
capital increase from earnings or capital surplus):
NT$ 76,999,230 and 7,699,923 shares
5.If adopting shelf registration, monetary value and number of shares
to be issued this time:NA
6.The remaining monetary value and shares after this issuance when
adopting shelf registration:NA
7.Par value per share:NA
8.Issue price:NA
9.Number of shares subscribed for by or allocated to employees:NA
10.Number of shares publicly sold:NA
11.Ratio of shares subscribed by or allotted as stock dividends to existing
shareholders: The shareholder will be entitled to receive 100 shares
in total for each 1,000 shares owned.
12.Handling method for fractional shares and shares unsubscripted for by
the deadline:
If the new shares distributed to shareholders from this
capital increase are less than one full share, shareholders
may consolidate them by handling respective procedures
at the Company's stock transfer agent.
For those shares which cannot be consolidated within the
specified period or still re main insufficient, cash will be
distributed instead (rounded to the dollar), and the Chairman shall
be authorized to designate specific persons for purchase of these by cash
at par value.
13.Rights and obligations of these newly issued shares:
same as existing shares
14.Utilization of the funds from the capital increase:
retained earnings.
15.Any other matters that need to be specified:
(1)If the outstanding shares changed due to the transactions, result in
the change to the dividend payout ratio, the final ratio will
be determined fully by the Board authorized by Shareholders Meeting.
(2)Rights and obligations of these newly issued shares are as existing
shares. If the issuance details needs to be changed requested by the
authorities, the Board will be authorized by Shareholders Meeting
to deal with related matters.
